Literature DB >> 24993881

The effect of low-molecular-weight heparin in cancer patients: the mirror image of survival?

Sandro Barni1, Erminio Bonizzoni2, Melina Verso3, Gualberto Gussoni4, Fausto Petrelli1, Tania Perrone5, Giancarlo Agnelli3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24993881      PMCID： PMC4125350          DOI： 10.1182/blood-2014-03-561761

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

Review 1.  The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials.

Authors:  A Lazo-Langner; G D Goss; J N Spaans; M A Rodger
Journal:  J Thromb Haemost       Date:  2007-04       Impact factor: 5.824

2.  The effect of LMWH (Nadroparin) on tumor progression.

Authors:  Zsuzsanna Nagy; Vera Turcsik; György Blaskó
Journal:  Pathol Oncol Res       Date:  2009-12       Impact factor: 3.201

3.  Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.

Authors:  Giancarlo Agnelli; Gualberto Gussoni; Carlo Bianchini; Melina Verso; Mario Mandalà; Luigi Cavanna; Sandro Barni; Roberto Labianca; Franco Buzzi; Giovanni Scambia; Rodolfo Passalacqua; Sergio Ricci; Giampietro Gasparini; Vito Lorusso; Erminio Bonizzoni; Maurizio Tonato
Journal:  Lancet Oncol       Date:  2009-08-31       Impact factor: 41.316
  3 in total
  4 in total

1.  Comparative outcomes of thrombocytopenic acute leukemic patients with venous thromboembolism at a Comprehensive Cancer Center.

Authors:  Maliha Khan; Travis M Cox; Mohammed Nassif; Mohanad A Alzubaidi; Naveen Garg; Wei Qiao; Fleur M Aung; Thein Hlaing Oo; Cristhiam M Rojas-Hernandez
Journal:  J Thromb Thrombolysis       Date:  2018-04       Impact factor: 2.300

Review 2.  Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Authors:  Marcello Di Nisio; Ettore Porreca; Matteo Candeloro; Michele De Tursi; Ilaria Russi; Anne Ws Rutjes
Journal:  Cochrane Database Syst Rev       Date:  2016-12-01

3.  Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Authors:  Anne Ws Rutjes; Ettore Porreca; Matteo Candeloro; Emanuele Valeriani; Marcello Di Nisio
Journal:  Cochrane Database Syst Rev       Date:  2020-12-18

Review 4.  Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma.

Authors:  Peyda Korhan; Yeliz Yılmaz; Ezgi Bağırsakçı; Ayşim Güneş; Hande Topel; Brian I Carr; Neşe Atabey
Journal:  Can J Gastroenterol Hepatol       Date:  2018-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.